Dimensional Fund Advisors LP Arcturus Therapeutics Holdings Inc. Transaction History

Dimensional Fund Advisors LP

$418 Billion
Q2 2025

A detailed history of Dimensional Fund Advisors LP transactions in Arcturus Therapeutics Holdings Inc. stock. As of the latest transaction made, Dimensional Fund Advisors LP holds 582,279 shares of ARCT stock, worth $8.67 Million. This represents 0.0% of its overall portfolio holdings.

Number of Shares

582,279

Previous 616,634 5.57%

Holding current value

$8.67 Million

Previous $6.53 Million 16.0%

% of portfolio

0.0%

Previous 0.0%

15 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2025 Aug 12, 2025	SELL	$8.91 - $14.41 $306,103 - $495,055	-34,355 Reduced 5.57%	582,279 $7.58 Million
Q1 2025 May 13, 2025	SELL	$10.59 - $20.83 $961,254 - $1.89 Million	-90,770 Reduced 12.83%	616,634 $6.53 Million
Q4 2024 Feb 13, 2025	SELL	$14.82 - $25.48 $1.26 Million - $2.17 Million	-85,196 Reduced 10.75%	707,404 $12 Million
Q3 2024 Nov 07, 2024	SELL	$18.08 - $25.38 $2.27 Million - $3.19 Million	-125,622 Reduced 13.68%	792,600 $18.4 Million
Q2 2024 Aug 09, 2024	SELL	$24.35 - $44.39 $4.52 Million - $8.24 Million	-185,598 Reduced 16.81%	918,222 $22.4 Million
Q1 2024 May 10, 2024	BUY	$31.23 - $42.99 $465,014 - $640,121	14,890 Added 1.37%	1,103,820 $37.3 Million
Q4 2023 Feb 07, 2024	BUY	$17.71 - $32.97 $2.04 Million - $3.79 Million	115,087 Added 11.82%	1,088,930 $34.3 Million
Q3 2023 Nov 09, 2023	BUY	$25.44 - $37.35 $7.1 Million - $10.4 Million	278,989 Added 40.15%	973,843 $24.9 Million
Q2 2023 Aug 09, 2023	BUY	$23.94 - $32.36 $4.99 Million - $6.74 Million	208,233 Added 42.79%	694,854 $19.9 Million
Q1 2023 May 12, 2023	BUY	$14.72 - $23.97 $2.7 Million - $4.4 Million	183,760 Added 60.67%	486,621 $11.7 Million
Q4 2022 Feb 09, 2023	BUY	$14.14 - $23.06 $2.26 Million - $3.68 Million	159,743 Added 111.62%	302,861 $5.14 Million
Q3 2022 Nov 10, 2022	SELL	$13.05 - $22.13 $81,875 - $138,843	-6,274 Reduced 4.2%	143,118 $2.12 Million
Q2 2022 Aug 12, 2022	SELL	$12.26 - $31.17 $835,886 - $2.13 Million	-68,180 Reduced 31.34%	149,392 $2.35 Million
Q1 2022 May 13, 2022	BUY	$17.64 - $39.57 $2.52 Million - $5.64 Million	142,633 Added 190.33%	217,572 $5.87 Million
Q4 2021 Feb 09, 2022	BUY	$34.2 - $47.56 $2.56 Million - $3.56 Million	74,939 New	74,939 $2.77 Million

Others Institutions Holding ARCT

# of Institutions

171

Shares Held

25.9M

Call Options Held

321K

Put Options Held

136K

View Full List

About Arcturus Therapeutics Holdings Inc.

Ticker ARCT
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 26,576,400
Market Cap $396M
Description
Arcturus Therapeutics Holdings Inc., an RNA medicines company, focuses on the development of vaccines for infectious, and liver and respiratory rare diseases in the United States. The company's development programs comprise LUNAR-OTC development program for ornithine transcarbamylase (OTC) deficiency; and LUNAR-CF program for cystic fibrosis lun...

More about ARCT

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Dimensional Fund Advisors LP, based on Form 13F filings with the SEC.

News

Stay updated on Dimensional Fund Advisors LP with notifications on news.

Account

Dimensional Fund Advisors LP Arcturus Therapeutics Holdings Inc. Transaction History